News

Filter

Janssen releases Phase II data for combination of simeprevir and sofosbuvir

Janssen releases Phase II data for combination of simeprevir and sofosbuvir

15-04-2014

US health care giant Johnson & Johnson’s Europe-based subsidiary Janssen has announced positive new…

Anti-viralsAntiviralsBiotechnologyGilead SciencesHealth Medical PharmaHepatitisJanssen BiotechProtease inhibitorsResearchsimeprevirsofosbuvirUSA

COMPANY SPOTLIGHT

Menarini

Back to top